Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transbronchial Versus Transthoracic Ablation for Early Stage Peripheral Lung Cancer: a Prospective, Randomized Controlled Trial

NCT06052098 is registered in ClinicalTrials.gov with Hangzhou Broncus Medical Co., Ltd. as lead sponsor.

NCT NCT06052098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06052098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transbronchial Versus Transthoracic Ablation for Early Stage Peripheral Lung Cancer: a Prospective, Randomized Controlled Trial
Lead sponsor
Hangzhou Broncus Medical Co., Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
October 11, 2023
Completion date
October 31, 2027
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ia lung cancer